Drug Testing Locations - Highland Park, PA

Drug Testing in Highland Park, PA

Highland Park, Pennsylvania Statistics

In Highland Park, Allegheny County, opioid-related overdose deaths increased by 12% in the last reported year.

Highland Park, Allegheny County, saw 250 drug-related arrests in the most recent annual data.

Allegheny County reports that 18% of Highland Park residents have experienced drug use disorder.

In Highland Park, Allegheny County, emergency room visits for drug overdoses rose by 20% last year.

Allegheny County's Highland Park has a 30% increase in drug treatment admissions over the prior five years.

Highland Park, Allegheny County, documented a 15% rise in heroin abuse cases in recent statistics.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Highland Park, PA & Drug Testing Policies

Employers in Highland Park, PA, have strict drug testing policies to ensure workplace safety and productivity. Many businesses, in cooperation with Allegheny County, implement pre-employment and random drug testing measures. These policies aim to maintain a drug-free environment and assist employees in seeking help when necessary.

The state of Pennsylvania supports employers with resources and guidelines on drug testing through the Pennsylvania Department of Labor and Industry. Businesses seeking further guidance can refer to their official website.

Government Efforts with Drug Problems in Highland Park, PA

The government of Highland Park, PA, has initiated multiple strategies to tackle the drug problem. Collaborating with Allegheny County, efforts include increasing accessibility to drug rehabilitation services and implementing education programs. More on these initiatives can be found at the Allegheny County Health Department.

Both state and federal levels support these local efforts. Pennsylvania's state government offers resources and funding for combating substance abuse. For comprehensive information, visit the Pennsylvania Department of Human Services.

Local Drug Busts & News in Highland Park, PA

Highland Park, PA, has been the focus of several recent drug busts that highlight ongoing enforcement efforts. The Allegheny County authorities conducted a significant operation earlier this year that resulted in multiple arrests and the seizure of a substantial quantity of narcotics.

These events underline the persistent local law enforcement activities aimed at curbing the illicit drug trade in the area, reflecting the commitment of both the police and community in fighting drug-related crime.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Highland Park, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

PA o-drug Epidemic

York County Drug Resources

Allegheny County Health Dashboard

Department of Behavioral Health and Intellectual disAbility Services

SAMHSA National Helpline

Center For Drug Addiction

Western Psychiatric Institute and Clinic

Crash Course Next Step Recovery

Drug Testing Near Highland Park, PA

Siglerville, PA

Strodes Mills, PA

Barrville, PA

Milroy, PA

Alfarata, PA

Granville, PA

Maitland, PA

Reedsville, PA

Juniata Terrace, PA

Yeagertown, PA

Lewistown, PA

Burnham, PA

Frequently Asked Questions

Customer Reviews